Immune Cell Levels Predict Skin Cancer Risk in Kidney Transplant Patients
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Immune Cell Levels Predict Skin Cancer Risk in Kidney Transplant Patients

WASHINGTON, DC -- January 28, 2010 -- Measuring certain types of immune cells may predict the high risk of skin cancer after kidney transplantation, according to a study published early online and appearing in an upcoming issue of the Journal of the American Society Nephrology.

“There are differences in the immune system, and some of these are associated with the development of skin cancer after transplantation,” commented Robert Carroll, MD, The
Queen Elizabeth Hospital, Woodville, South Australia.

The researchers measured levels of key immune cells in 116 kidney transplant recipients, 65 of whom developed squamous cell skin cancers.

“We were hoping to see if there were differences in the immune systems of patients who developed skin cancer after transplantation compared with those who did not develop skin cancer,” said Dr. Carroll.

The results showed that patients with high levels of Tregulatory cells together with low levels of Natural Killer cells had risk more than 5 times higher.

The high risk of skin cancers after kidney transplantation is related to the use of immunosuppressive drugs to prevent rejection. “Squamous cell cancer of the skin affects about 30% of kidney transplant patients after 10 years of immunosuppression,” explained Dr. Carroll explains. “A small number of patients develop multiple skin cancers per year, but there is no laboratory test to determine which transplant recipients will develop multiple skin cancers in the future.”

If confirmed by future studies, measuring immune cells could provide a valuable new approach to predicting the risk of skin cancer after kidney transplantation. “If a test can confirm high risk of skin cancer development, this may help clinicians to tailor immunosuppressive regimens for individual patients,” said Dr. Carroll.

The study was limited to British transplant patients. Well-designed scientific studies will be needed to determine whether the immune system test will apply to other populations of patients around the world, with different immunosuppressive regimens and differing exposure to ultraviolet light.

SOURCE: American Society of Nephrology

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities